These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 9396701

  • 1. Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease.
    Nevo Y, Pestronk A.
    J Infect Dis; 1997 Dec; 176 Suppl 2():S154-6. PubMed ID: 9396701
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
    Bech E, Orntoft TF, Andersen LP, Skinhøj P, Jakobsen J.
    J Neuroimmunol; 1997 Jan; 72(1):59-66. PubMed ID: 9003245
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
    Hao Q, Saida T, Kuroki S, Nishimura M, Nukina M, Obayashi H, Saida K.
    J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA, Koblar S, Hughes RA.
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunoadsorption therapy in Guillain-Barré syndrome.
    Hirai K, Kihara M, Nakajima F, Miyanomae Y, Yoshioka H.
    Pediatr Neurol; 1998 Jul; 19(1):55-7. PubMed ID: 9682887
    [Abstract] [Full Text] [Related]

  • 14. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
    Rees JH, Gregson NA, Hughes RA.
    J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Prendergast MM, Willison HJ, Moran AP.
    Infect Immun; 1999 Jul; 67(7):3698-701. PubMed ID: 10377164
    [Abstract] [Full Text] [Related]

  • 18. Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori.
    Johansen HK, Nørgaard A, Andersen LP, Jensen P, Nielsen H, Høiby N.
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):149-55. PubMed ID: 7697522
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses.
    Ogino M, Orazio N, Latov N.
    J Neuroimmunol; 1995 Apr; 58(1):77-80. PubMed ID: 7730449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.